Recombinant Anti-IL1α x Anti-IL1β Bispecific Antibody (IgG-Fv) (BSGV-177)

Recombinant Anti-IL1α x Anti-IL1β Bispecific Antibody (IgG-Fv) is formed by an Immunoglobulin G (IgG) and a fragment variable Fv region, in which the Fc of IgG is engineered by KIH. The Fv region of an anti-IL1α antibody variable domain is fused to the C terminal of an IgG of anti-IL1β antibody, or vice versa. The format retains desired characteristics of intact antibodies. This BsAb can block two proinﬂammatory cytokines simultaneously. It is designed for the research of Osteoarthritis (OA) therapy.

Datasheet INQUIRY

Specifications

Targets

IL1α & IL1β

Type

IgG-Fv

Species Reactivity

Human

Application

FuncS; Promising therapeutic agent

Related Disease

Osteoarthritis (OA)

Targets

Target 1

IL1α

Gene ID

3552

UniProt ID

P01583

Alternative Names

IL1; IL-1A; IL1F1; IL1-ALPHA; Interleukin 1 alpha; hematopoietin 1; IL1α

Target 2

IL1β

Gene ID

3553

UniProt ID

P01584

Alternative Names

IL-1; IL1F2; IL1-BETA; IL1β; Interleukin-1β; IL-1β

Our products and services are for research use only, and not for use in diagnostic or therapeutic procedures.

Online Inquiry

Customer Reviews and Q&As

There are currently no customer reviews or questions for Recombinant Anti-IL1α x Anti-IL1β Bispecific Antibody (IgG-Fv) (BSGV-177). Click the button below to contact us or submit your feedback about this product.

Recombinant Anti-IL1α x Anti-IL1β Bispecific Antibody (IgG-Fv) (CAT#: BSGV-177)

Specifications

Targets

Customer Reviews and Q&As